Chronic oral pelargonidin alleviates streptozotocin-induced diabetic neuropathic hyperalgesia in rat: Involvement of oxidative stress

Iranian Biomedical Journal

Volumn 14, Issue 1-2, 2010, Pages 33-39

  Mirshekar, Mohammadali ^a   Roghani, Mehrdad ^a   Khalili, Mohsen ^a   Baluchnejadmojarad, Tourandokht ^b   Moazzen, Saiedeh Arab ^c  

^a SHAHED UNIVERSITY   (Iran)

^b IRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c ISLAMIC AZAD UNIVERSITY   (Iran)

Author keywords

Oxidative stress; Pelargonidin (PG); Streptozotocin (STZ)

Indexed keywords

FORMALDEHYDE; GLUCOSE; MALONALDEHYDE; NITRITE; PELARGONIDIN; SALICYLATE SODIUM; STREPTOZOCIN; SUPEROXIDE DISMUTASE; THIOBARBITURIC ACID REACTIVE SUBSTANCE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CHRONIC DRUG ADMINISTRATION; CONTROLLED STUDY; DIABETIC NEUROPATHY; DISEASE COURSE; DRUG DOSE REGIMEN; DRUG EFFECT; DRUG RESPONSE; ENZYME INHIBITION; GLUCOSE BLOOD LEVEL; HYPERALGESIA; LIPID PEROXIDATION; MALE; NONHUMAN; OXIDATIVE STRESS; RAT; TAIL FLICK TEST; TREATMENT DURATION;

ADMINISTRATION, ORAL; ANIMALS; ANTHOCYANINS; DIABETES MELLITUS, EXPERIMENTAL; DIABETIC NEUROPATHIES; FREE RADICAL SCAVENGERS; HYPERALGESIA; MALE; NITRITES; OXIDATIVE STRESS; PAIN MEASUREMENT; RATS; RATS, WISTAR; SUPEROXIDE DISMUTASE; THIOBARBITURIC ACID REACTIVE SUBSTANCES;

RATTUS; RATTUS NORVEGICUS;

EID: 79851501685     PISSN: 1028852X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (34)

1. Wild, S., Roglic, G., Green, A., Sicree, R. and King, H. (2004) Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care 27 (5): 1047-1053.
2. Sima, A.A. and Sugimoto, K. (1999) Experimental diabetic neuropathy: an update. Diabetologia 42 (7): 773-788.
3. Van Dam, P.S. (2002) Oxidative stress and diabetic neuropathy: pathophysiological mechanisms and treatment perspectives. Diabetes Metab. Res. Rev. 18 (3): 176-184.
4. Obrosova, I.G. (2003) Update on the pathogenesis of diabetic neuropathy. Curr. Diab. Rep. 3 (6): 439-445.
5. Vincent, A.M., Russell, J.W., Low, P. and Feldman, E.L. (2004) Oxidative stress in the pathogenesis of diabetic neuropathy. Endocr. Rev. 25 (4): 612-628.
6. Nickander, K.K., McPhee, B.R., Low, P.A. and Tritschler, H. (1996) Alpha-lipoic acid: antioxidant potency against lipid peroxidation of neural tissues in vitro and implications for diabetic neuropathy. Free Radic. Biol. Med. 21 (5): 631-639.
7. Cameron, N.E. and Cotter, M.A. (1999) Effects of antioxidants on nerve and vascular dysfunction in experimental diabetes. Diabetes Res. Clin. Pract. 45 (2-3): 137-146.
8. Laight, D.W., Carrier, M.J. and Anggard, E.E. (2000) Antioxidants, diabetes and endothelial dysfunction. Cardiovasc. Res. 47 (3): 457-464.
9. Machha, A. and Mustafa, M.R. (2005) Chronic treatment with flavonoids prevents endothelial dysfunction in spontaneously hypertensive rat aorta. J. Cardiovasc. Pharmacol. 46 (1):36-40.
10. Cherian, S. and Augusti, K.T. (1993) Antidiabetic effects of a glycoside of leucopelargonidin isolated from Ficus bengalensis Linn. Indian J. Exp. Biol. 31 (1): 26-29.
11. Roy, M., Sen, S. and Chakraborti, A.S. (2008) Action of pelargonidin on hyperglycemia and oxidative damage in diabetic rats: implication for glycationinduced hemoglobin modification. Life Sci. 82 (21-22): 1102-1110.
12. Dreiseitel, A., Schreier, P., Oehme, A., Locher, S., Rogler, G., Piberger, H., Hajak, G. and Sand, P.G. (2008) Inhibition of proteasome activity by anthocyanins and anthocyanidins. Biochem. Biophys. Res. Commun. 372 (1): 57-61.
13. Noda, Y., Kaneyuki, T., Mori, A. and Packer, L. (2002) Antioxidant activities of pomegranate fruit extract and its anthocyanidins: delphinidin, cyanidin, and pelargonidin. J. Agric. Food Chem. 50: 166-171.
14. Dubuisson, D. and Dennis, S.G. (1977) The formalin test: a quantitative study of the analgesic effects of morphine, meperidine and brain stem stimulation in rats and cats. Pain 4 (2): 161-174.
15. Courteix, C., Eschalier, A. and Lavarenne, J. (1993) Streptozotocin-induced diabetic rats: behavioral evidence for a model of chronic pain. Pain (53): 81-88.
16. Roghani, M. and Baluchnejadmojarad, T. (2009) Chronic epigallocatechin-gallate improves aortic reactivity of diabetic rats: underlying mechanisms. Vascul. Pharmacol. 51(2-3): 84-89.
17. Bradford, M.M. (1976) A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72: 248-254.
18. Cotter, M.A., Jack, A.M. and Cameron, N.E. (2002) Effects of the protein kinase C beta inhibitor LY333531 on neural and vascular function in rats with streptozotocin-induced diabetes. Clin. Sci. (Lond) 103 (3): 311-321.
19. Coppey, L.J., Gellett, J.S., Davidson, E.P., Dunlap, J.A. and Yorek, M.A. (2002) Effect of treating streptozotocin-induced diabetic rats with sorbinil, myo-inositol or aminoguanidine on endoneurial blood flow, motor nerve conduction velocity and vascular function of epineurial arterioles of the sciatic nerve. Int. J. Exp. Diabetes Res. 3 (1): 21-36.
20. Freshwater, J.D., Svensson, C.I., Malmberg, A.B. and Calcutt, N.A. (2002) Elevated spinal cyclooxygenase and prostaglandin release during hyperalgesia in diabetic rats. Diabetes 51 (7): 2249-2255.
21. Fox, A., Eastwood, C., Gentry, C., Manning, D. and Urban, L. (1999) Critical evaluation of the streptozotocin model of painful diabetic neuropathy in the rat. Pain 81 (3): 307-316.
22. Dobretsov, M., Hastings, S.L., Stimers, J.R. and Zhang, J.M. (2001) Mechanical hyperalgesia in rats with chronic perfusion of lumbar dorsal root ganglion with hyperglycemic solution. J. Neurosci. Methods 110 (1-2): 9-15.
23. Malcangio, M. and Tomlinson, D.R. (1998) A pharmacologic analysis of mechanical hyperalgesia in streptozotocin-diabetic rats. Pain 76 (1-2): 151-157.
24. Rutledge, L.P., Ngong, J.M., Kuperberg, J.M., Samaan, S.S., Soliman, K.F. and Kolta, M.G. (2002) Dopaminergic system modulation of nociceptive response in long-term diabetic rats. Pharmacol. Biochem. Behav. 74 (1): 1-9.
25. Gullapalli, S., Gurumoorthy, K., Kaul, C.L. and Ramarao, P. (2002) Role of L-type Ca2+ channels in attenuated morphine antinociception in streptozotocin-diabetic rats. Eur. J. Pharmacol. 435 (2): 187-194.
26. Nourooz-Zadeh, J., Rahimi, A., Tajaddini-Sarmadi, J., Tritschler, H., Rosen, P., Halliwell, B. and Betteridge, D.J. (1997) Relationships between plasma measures of oxidative stress and metabolic control in NIDDM. Diabetologia 40 (6): 647-653.
27. Wohaieb, S.A. and Godin, D.V. (1987) Alterations in free radical tissue-defense mechanisms in streptozocin-induced diabetes in rat: Effects of insulin treatment. Diabetes 36 (9): 1014-1018.
28. Feillet-Coudray, C., Rock, E., Coudray, C., Grzelkowska, K., Azais-Braesco, V., Dardevet, D. and Mazur, A. (1999) Lipid peroxidation and antioxidant status in experimental diabetes. Clin. Chem. Acta 284 (1): 31-34.
29. Toleikis, P.M. and Godin, D.V. (1995) Alteration of antioxidant status in diabetic rats by chronic exposure to psychological stressors. Pharmacol. Biochem. Behav. 52 (2): 355-366.
30. Sen, C.K. (1995) Oxygen toxicity and antioxidants: state of the art. Indian J. Physiol. Pharmacol. 39 (3): 177-196.
31. Shibata, M., Ohkubo, T., Takahashi, H. and Inoki, R. (1989) Modified formalin test: characteristic biphasic pain response. Pain 38 (3): 347-352.
32. Rosland, J.H., Tjolsen, A., Maehle, B. and Hole, K. (1990) The formalin test in mice: effect of formalin concentration. Pain 42 (2): 235-242.
33. Jayaprakasam, B., Vareed, S.K., Olson, L.K. and Nair, M.G. (2005) Insulin secretion by bioactive anthocyanins and anthocyanidins present in fruits. J. Agric. Food Chem. 53(1): 2519-2523.
34. Prince, P.S.M. and Kamalakkannan, N. (2006) Rutin improves glucose homeostasis in streptozotocin diabetic tissues by altering glycolytic and gluconeogenic enzymes. J. Biochem. Mol. Toxicol. 20 (2): 96-102.